Trial Site News
Generic selectors
Exact matches only
Search in title
Search in content
Search in posts
Search in pages
  • Register
  • Log In
  • News
  • Video
  • Podcast
  • More
Trial Site News
  • News For You
  • Op-Eds
  • Video
  • Podcasts
  • Investor Watch
  • Write for us
  • News for You
  • Op-Eds
  • Video
  • Podcasts
  • Covid-19
  • Investor Watch

Topic: Denmark

University of Copenhagen Spin-out Raises $154m Targeting Novel Immune-Modulating Anti-Cancer Therapies

IO Biotech, a Danish clinical-stage biotech venture developing novel, immune-modulating anti-cancer therapies based on its proprietary T-win® technology raised EUR […]

University of Copenhagen Spin-out Raises $154m Targeting Novel Immune-Modulating Anti-Cancer Therapies
2 months ago
Share

Fujifilm Doubles Down in Denmark worth $928m as that Small Nation Emerges Big as Leader in Bio-CDMO Activity

Japan’s FUJIFILM is making some big bets in a small country with a $928 million capital injection into its FUJIFILM […]

Fujifilm Doubles Down in Denmark worth $928m as that Small Nation Emerges Big as Leader in Bio-CDMO Activity
9 months ago
Share

Aarhus University Hospital Large Cohort Study Reveals in Denmark Overweight and Obesity Increases are Associated with Cancer

Researchers Aarhus University Hospital in Denmark conducted a study associating hospital-diagnosed overweight and obesity with an increased risk of a […]

Aarhus University Hospital Large Cohort Study Reveals in Denmark Overweight and Obesity Increases are Associated with Cancer
1 year ago
Share

Odense University Hospital Screens First Patient for Phase IIb Prostate Cancer ‘BRaVac’ Study Assessing RV001

Odense University Hospital screen first patient for phase IIb prostate cancer “BRaVac” study assessing drug candidate RV001. The lead investigator […]

Odense University Hospital Screens First Patient for Phase IIb Prostate Cancer ‘BRaVac’ Study Assessing RV001
1 year ago
Share

Bispebjerg Hospital Study Reveals Hidradenitis Suppurativa Associated with Multiple Comorbidities

Patients struggling with hidradenitis suppurativa face higher risks for cardiovascular (CV) and psychiatric disorders which often go unrecognized and untreated […]

Bispebjerg Hospital Study Reveals Hidradenitis Suppurativa Associated with Multiple Comorbidities
1 year ago
Share

Aarhus University Hospital Study Reports Migraine Complicates Pregnancy

Aahrus University Hospital Denmark conducted a recent study that has revealed that migraine is associated with an increased risk in […]

Migraine and Pregnancy
2 years ago
Share

Aarhus University Hospital 75,000 Patient Study Identifying Hip Fracture Infection Risk

Aarhus University Hospital, Denmark researchers utilized data from 75,000 hip fractures in Denmark targeting the issue of postop infection and […]

2 years ago
Share

Aarhus University Investigators Make Breakthrough Studying Hereditary Angioedema (HAE)

As reported in EurekAlert! researchers from Denmark’s Aarhus University have unveiled cellular defects leading to the rare disease hereditary angioedema […]

2 years ago
Share

Novel Treatment for Patients with Endocarditis

Melissa Gray reports that according to the late-breaking outcomes of the POET trial, the novel treatment plan can minimize the […]

2 years ago
Share

Common Painkillers Double Risk of Heart Attack, Stroke

Najja Parker of the Atlanta Journal-Constitution reports that many people reach for painkillers to get rid of headaches or reduce […]

3 years ago
Share

Latest Podcasts

Alan Cannell talks COVID-19: Nobody Likes Cheap Solutions | Podcast S2 E41

Dr. Pierre Kory Talks Covid-19, Ivermectin and the FLCCC | Podcast E43

An Interview With Patricia Carter: Patient Engagement and Retention in Clinical Trials

Dr. Negin Hajizadeh: Researchers Finding A Very Effective Treatment For Covid-19 In New Study

Dr. Jean-Jacques Rajter and Dr. Juliana Cepelowicz Rajter Discuss Ivermectin In Broward County | Podcast S2 E 27

159 W Broadway, Suite 200
Salt Lake City, UT 84101

[email protected]

Connect With Us

TRIALSITE NEWS IS THE ONLY DIGITAL MEDIA DEDICATED 100% TO TRANSPARENT AND OPEN COVERAGE OF CLINICAL RESEARCH TRIAL SITES AROUND THE GLOBE. BASED IN THE SILICON SLOPES IN DOWNTOWN SALT LAKE CITY, UTAH, WE ARE FOUNDED BY A TEAM OF EXPERTS IN THE CLINICAL TRIALS INDUSTRY AND DEDICATED TO TRANSPARENCY, QUALITY AND CLINICAL TRIAL INNOVATION.

© 2021 TRIALSITE NEWS. ALL RIGHTS RESERVED.